Can a dissolving tablet improve recovery after a common stroke?
NCT ID NCT07721545
First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This trial tests whether Y-6 sublingual tablets can help people recover from a specific type of stroke called acute perforator artery infarction. About 944 adults who have had a stroke within the past 72 hours will receive either Y-6 or a placebo twice daily for 90 days. Researchers will measure functional outcomes, such as the ability to perform daily activities, and monitor for side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- an experimental drug called Y-6, given as a sublingual tablet
- What this could lead to
- If effective, Y-6 could offer a new treatment option for a common type of stroke, potentially reducing long-term disability.
- What could go wrong
- This is an early-to-mid-stage trial, so the drug may not prove more effective than placebo. Safety and optimal dosing are still being evaluated.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAI are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing TianTan Hospital
Beijing, Beijing Municipality, 100070, China
Contact Phone: •••-•••-•••• Email: •••••@•••••